Results 191 to 200 of about 3,057,452 (297)

Direct observations of atmospheric oxidized mercury speciation in polar areas. [PDF]

Nat Commun
Jokinen T, Gómez Martín JC, Feinberg A, Mahajan AS, Plane JMC, Ulises Acuña A, Cuevas C, Dávalos JZ, Quéléver LLJ, Laurila T, Beck I, Schmale J, Junninen H, Sipilä M, Kulmala M, Petäjä T, Saiz-Lopez A.   +16 more
europepmc   +1 more source

Laboratory of Microbiology, The Institute for Physical and Chemical Research (RIKEN)

JOURNAL OF THE BREWING SOCIETY OF JAPAN, 1998
Atsumi NAKAZATO, Toshimori KADOKURA, Kyoko YAMAMOTO, Tadashi HARAYAMA, Moriya OHKUMA, Masahisa TAKEDA, Toshiaki KUDO, Takichi KANEKO   +7 more
openaire   +2 more sources

Insights into a long life without cancer: The case of the bowhead whale

Molecular Oncology, EarlyView.
Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley   +1 more source

AI-Assisted Design of Chemically Recyclable Polymers for Food Packaging. [PDF]

Polymers (Basel)
Phan BK, Kim C, Nistane J, Xiong W, Chen H, Jang WJ, Gholami F, Su Y, Qi J, Lively R, Gutekunst W, Ramprasad R.   +11 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Effect of Distillation Time on the Yield and Chemical Composition of Leaf Essential Oil from <i>Abies koreana</i>. [PDF]

Plants (Basel)
Park C, Kim N, Jang SK, Park MJ.
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Cosmic ray-driven electron-induced reaction theory does not quantify spatiotemporal variations in lower-stratospheric ozone and temperature. [PDF]

Proc Natl Acad Sci U S A
Godin-Beekmann S, Chipperfield MP, Müller R, Neu JL, Newman PA, Santee ML, Solomon S, Tarasick D, Thompson AM, Wang Z.   +9 more
europepmc   +1 more source

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen, Jiancheng Cheng, Ruili Hou, Xiaoyuan Zheng, Li Su, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Johan Staaf, Åslaug Helland, Manel Esteller, David C. Christiani, Feng Chen, Xiaofei Cao, Ruyang Zhang   +14 more
wiley   +1 more source